StockNews.com began coverage on shares of Park City Group (NASDAQ:PCYG – Free Report) in a report issued on Friday. The firm issued a hold rating on the technology company’s stock.
Park City Group Price Performance
Shares of NASDAQ:PCYG opened at $14.95 on Friday. The firm has a market capitalization of $271.72 million, a PE ratio of 55.37 and a beta of 1.10. The business has a 50-day moving average of $16.11 and a two-hundred day moving average of $14.00. Park City Group has a 12 month low of $4.80 and a 12 month high of $10.50.
Institutional Investors Weigh In On Park City Group
Several institutional investors and hedge funds have recently added to or reduced their stakes in PCYG. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Park City Group during the third quarter worth about $125,000. O Shaughnessy Asset Management LLC grew its stake in shares of Park City Group by 115.4% in the third quarter. O Shaughnessy Asset Management LLC now owns 41,932 shares of the technology company’s stock valued at $367,000 after buying an additional 22,469 shares in the last quarter. Finally, Citigroup Inc. grew its stake in shares of Park City Group by 350,300.0% in the third quarter. Citigroup Inc. now owns 28,032 shares of the technology company’s stock valued at $246,000 after buying an additional 28,024 shares in the last quarter. 26.36% of the stock is currently owned by institutional investors and hedge funds.
Park City Group Company Profile
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Featured Stories
- Five stocks we like better than Park City Group
- Golden Cross Stocks: Pattern, Examples and Charts
- Sarepta Therapeutics Stock Soars on FDA Approval
- Health Care Stocks Explained: Why You Might Want to Invest
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Receive News & Ratings for Park City Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Park City Group and related companies with MarketBeat.com's FREE daily email newsletter.